BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36994203)

  • 1. Development and validation of machine learning models to predict survival of patients with resected stage-III NSCLC.
    Jin L; Zhao Q; Fu S; Cao F; Hou B; Ma J
    Front Oncol; 2023; 13():1092478. PubMed ID: 36994203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a deep learning model to predict survival of patients with esophageal cancer.
    Huang C; Dai Y; Chen Q; Chen H; Lin Y; Wu J; Xu X; Chen X
    Front Oncol; 2022; 12():971190. PubMed ID: 36033454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who can benefit from postmastectomy radiotherapy among HR+/HER2- T1-2 N1M0 breast cancer patients? An explainable machine learning mortality prediction based approach.
    Jin L; Zhao Q; Fu S; Zhang Y; Wu S; Li X; Cao F
    Front Endocrinol (Lausanne); 2024; 15():1326009. PubMed ID: 38375194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel deep learning prognostic system improves survival predictions for stage III non-small cell lung cancer.
    Yang L; Fan X; Qin W; Xu Y; Zou B; Fan B; Wang S; Dong T; Wang L
    Cancer Med; 2022 Nov; 11(22):4246-4255. PubMed ID: 35491970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
    She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
    JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intelligent prognosis evaluation system for stage I-III resected non-small-cell lung cancer patients on CT images: a multi-center study.
    Zhang S; Liu X; Zhou L; Wang K; Shao J; Shi J; Wang X; Mu J; Gao T; Jiang Z; Chen K; Wang C; Wang G
    EClinicalMedicine; 2023 Nov; 65():102270. PubMed ID: 38106558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
    He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
    Front Immunol; 2022; 13():835630. PubMed ID: 35401554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
    Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Robinson EJ; Orton M; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
    EBioMedicine; 2022 Mar; 77():103911. PubMed ID: 35248997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study.
    Xiao J; Mo M; Wang Z; Zhou C; Shen J; Yuan J; He Y; Zheng Y
    JMIR Med Inform; 2022 Feb; 10(2):e33440. PubMed ID: 35179504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
    Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
    Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
    Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
    JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning models for predicting the survival of patients with chondrosarcoma based on a surveillance, epidemiology, and end results analysis.
    Yan L; Gao N; Ai F; Zhao Y; Kang Y; Chen J; Weng Y
    Front Oncol; 2022; 12():967758. PubMed ID: 36072795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of survival prediction model for gastric adenocarcinoma patients using deep learning: A SEER-based study.
    Zeng J; Li K; Cao F; Zheng Y
    Front Oncol; 2023; 13():1131859. PubMed ID: 36959782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques.
    Cui Y; Wang Q; Shi X; Ye Q; Lei M; Wang B
    Front Oncol; 2022; 12():1095059. PubMed ID: 36568149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Proposal to Reflect Survival Difference and Modify the Staging System for Lung Adenocarcinoma and Squamous Cell Carcinoma: Based on the Machine Learning.
    Li M; Zhan C; Sui X; Jiang W; Shi Y; Yang X; Feng M; Wang J; Wang Q
    Front Oncol; 2019; 9():771. PubMed ID: 31475114
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of deep learning-based recurrence-free survival with random survival forest and Cox proportional hazard models in Stage-I NSCLC patients.
    Kar İ; Kocaman G; İbrahimov F; Enön S; Coşgun E; Elhan AH
    Cancer Med; 2023 Sep; 12(18):19272-19278. PubMed ID: 37644818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
    Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
    Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy.
    Zeng Y; Mayne N; Yang CJ; Liu J; Cui F; Li J; Liang W; He J;
    Transl Lung Cancer Res; 2021 Apr; 10(4):1690-1699. PubMed ID: 34012785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model.
    Matsuo K; Purushotham S; Jiang B; Mandelbaum RS; Takiuchi T; Liu Y; Roman LD
    Am J Obstet Gynecol; 2019 Apr; 220(4):381.e1-381.e14. PubMed ID: 30582927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
    Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
    Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.